id:"swepub:oai:DiVA.org:uu-947"
Search: id:"swepub:oai:DiVA.org:uu-947" > The pharmacokinetic...
- 1 of 1
- Previous record
- Next record
- To hitlist
The pharmacokinetics and pharmacodynamics of clevidipine, a new ultrashort-acting calcium antagonist, in different animal species and man
-
- Ericsson, Hans (author)
- Uppsala universitet,Institutionen för farmaci
- (creator_code:org_t)
- ISBN 9155443931
- Uppsala : Acta Universitatis Upsaliensis, 1999
- English 64 s.
- Series: Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, 0282-7484 ; 198
- Doctoral thesis (other academic/artistic)
Abstract
Subject headings
Close
- Clevidipine is a new ultrashort-acting calcium antagonist of the dihydropyridine type developed for reduction and control of blood pressure in connection with cardiac surgery. The aim of this thesis was to characterise the in vitro hydrolysis rate of clevidipine in different biological matrices and the pharmacokinetics and pharmacodynamics in animal species and various human populations. The data analyses were performed in WinNonlin and PPHARM.Clevidipine is rapidly metabolised in blood and extravascular tissues to an inactive carboxylic acid. The hydrolysis in human blood seems to be mediated primarily by esterase(s) associated with the red blood cells and is temperature dependent. Both clevidipine and the individual enantiomers are more than 99.5% bound to plasma proteins. In all species studied, clevidipine is a high clearance drug with a small volume of distributionand an extremely short half-life. The initial rapid decline following cessation of clevidipine infusion is mainly due to elimination and the resulting context-sensitive half-time in man is approximately 1 minute regardless of the duration of the infusion. The twofold difference between the clevidipine concentration in arterial and venous blood in man during ongoing infusion demonstrates the importance of taking this arteriovenous difference into account in the PK/PD analysis. The reductions in the ratio of mean arterial blood pressure and heart rate in healthy subjects and essential hypertensive patients are similar, although a more pronounced decrease in blood pressure is observed in the latter population. The reduced clearance during cardiopulmonary bypass is probably related to the lower body temperature during this condition. The initial rapid increase in the arterial blood concentrations and the short equilibrium time between the blood and the biophase suggest that clevidipine can berapidly titrated to the desired effect in cardiac surgical patients in whom acute changes in blood pressure frequently occur.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)
Keyword
- Pharmacy
- FARMACI
- PHARMACY
- FARMACI
- Biopharmaceutics
- biofarmaci
Publication and Content Type
- vet (subject category)
- dok (subject category)
Find in a library
- The pharmacokinetics and pharmacodynamics of clevidipine, a new ultrashort-actin... (Search the publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Ericsson, Hans
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Basic Medicine
- and Pharmaceutical S ...
- Parts in the series
- Comprehensive Su ...
- By the university
- Uppsala University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
